Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Masked Parallel Evaluation of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances

NCT01703559 is registered in ClinicalTrials.gov with Opus Genetics, Inc as lead sponsor.

NCT NCT01703559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01703559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Masked Parallel Evaluation of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances
Lead sponsor
Opus Genetics, Inc
Phase
Phase 2
Overall status
Completed
Start date
September 9, 2011
Completion date
April 30, 2012
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decrease in night vision, disturbance; vision, loss, night vision complaints